Literature DB >> 12844073

[Multidetector CT and MRI in diseases of the gastrointestinal tract].

J-M Bruel1, B Gallix, C Achard, M-A Pierredon, E Molina.   

Abstract

UNLABELLED: With the introduction of spiral scanning then multidetector technologies, the accuracy for diagnosing digestive tract diseases with CT has been highly improved, and CT is used more and more in the evaluation of patients with suspected gastrointestinal disorders. CT is able to demonstrate both the intramural and the extramural components of the disease, and has a major role in the preoperative staging and the follow-up. Improvements of CT protocols, such as CT-enteroclysis, or multiplanar 2D and 3D post-processing, including now techniques for "virtual endoscopy", lead to discuss new indications in which CT could now compete with conventional X-rays series and videoendoscopy. This precise study of the digestive wall, the peridigestive fat, the digestive tract blood supply, may be performed by MRI, under the condition of access to high level machines and standardized protocols. MR-enteroclysis and MR-virtual colonoscopy could be performed with much lower risk for the patient, in terms of radiation dose or contrast adverse effects. Endoluminal coils should give to MR an ultra-high resolution for analysing the different layers of the gastrointestinal wall. LEARNING
OBJECTIVES: to review how to perform CT and MRI protocols for digestive tract imaging, to recognize the CT and MR patterns of the main digestive tract diseases, to discuss the value, limits and role of CT and MR in digestive tract diseases, to discuss the potential role of CT and MR new technological developments for digestive tract imaging in the upcoming future.
CONCLUSION: CT is nowadays a modality of choice for digestive imaging. Improvements in technologies and indications, the necessary discussion of the risks and benefits for the patient should let the radiologists consider MRI in gastrointestinal disorders as an important part of the routine activity in clinical MRI.

Entities:  

Mesh:

Year:  2003        PMID: 12844073

Source DB:  PubMed          Journal:  J Radiol        ISSN: 0221-0363


  6 in total

1.  Clinical presentations and surgical approach of acute intussusception caused by Peutz-Jeghers syndrome in adults.

Authors:  Hong Wang; Ting Luo; Wen-Qu Liu; Yan Huang; Xiao-Ting Wu; Xiu-Jie Wang
Journal:  J Gastrointest Surg       Date:  2011-10-18       Impact factor: 3.452

2.  Magnetic resonance colonography in severe attacks of ulcerative colitis.

Authors:  C Savoye-Collet; J B Roset; E Koning; C Charpentier; S Hommel; E Lerebours; J N Dacher; G Savoye
Journal:  Eur Radiol       Date:  2012-04-27       Impact factor: 5.315

3.  Multidetector computed tomography enteroclysis (MDCT-E) with neutral enteral and IV contrast enhancement in tumor detection.

Authors:  Stefania Romano; Elisabetta De Lutio; Gian Andrea Rollandi; Luigia Romano; Roberto Grassi; Dean D T Maglinte
Journal:  Eur Radiol       Date:  2005-04-07       Impact factor: 5.315

4.  Clinical spectrum and surgical approach of adult intussusceptions: a multicentric study.

Authors:  M Barussaud; N Regenet; X Briennon; B de Kerviler; P Pessaux; N Kohneh-Sharhi; P A Lehur; A Hamy; J Leborgne; J C le Neel; E Mirallie
Journal:  Int J Colorectal Dis       Date:  2005-06-11       Impact factor: 2.571

5.  Multidetector CT enteroclysis: comparison of the reading performance for axial and coronal views.

Authors:  Sabine Schmidt; Patrick Chevallier; Marc Chalaron; Bertrand Bessoud; Francis R Verdun; Philippe Frascarolo; Pierre Schnyder; Alban Denys
Journal:  Eur Radiol       Date:  2004-11-24       Impact factor: 5.315

6.  A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase.

Authors:  Lars Ny; Hua Li; Shankar Mukherjee; Katarina Persson; Bo Holmqvist; Dazhi Zhao; Vitaliy Shtutin; Huan Huang; Louis M Weiss; Fabiana S Machado; Stephen M Factor; John Chan; Herbert B Tanowitz; Linda A Jelicks
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.